Link to this page
Orphanet Rare Disease Ontology
Last uploaded:
December 4, 2024
Jump to:
| Preferred Name | Acromegaly | |
| Synonyms |
|
|
| Definitions |
A rare acquired endocrine disease related to excessive production of growth hormone (GH) and characterized by progressive somatic disfigurement (mainly involving the face and extremities) and systemic manifestations. |
|
| ID |
http://www.orpha.net/ORDO/Orphanet_963 |
|
| definition |
A rare acquired endocrine disease related to excessive production of growth hormone (GH) and characterized by progressive somatic disfigurement (mainly involving the face and extremities) and systemic manifestations.
|
|
| definition_citation |
Orphanet
|
|
| expertlink |
https://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=en&Expert=963 |
|
| has_age_of_onset |
Adolescent Adult Childhood Elderly Infancy
|
|
| has_inheritance |
Not applicable
|
|
| hasDbXref |
OMIM:102200 OMIM:300943 ICD-11:5A60.0 MeSH:D000172 MedDRA:10000599 ICD-10:E22.0 UMLS:C0001206
|
|
| label |
Acromegaly
|
|
| notation |
ORPHA:963
|
|
| part_of | ||
| prefixIRI |
ORDO:Orphanet_963
|
|
| prefLabel |
Acromegaly
|
|
| present_in |
Worldwide AND has_annual_incidence_average_value : 0.47 AND has_annual_incidence_range : 1-9 / 1 000 000 Finland AND has_annual_incidence_average_value : 0.34 AND has_annual_incidence_range : 1-9 / 1 000 000 Belgium AND has_point_prevalence_average_value : 12.0 AND has_point_prevalence_range : 1-5 / 10 000 Denmark AND has_annual_incidence_average_value : 0.38 AND has_annual_incidence_range : 1-9 / 1 000 000 Korea, Republic of AND has_point_prevalence_average_value : 2.79 AND has_point_prevalence_range : 1-9 / 100 000 Malta AND has_point_prevalence_average_value : 12.5 AND has_point_prevalence_range : 1-5 / 10 000 Denmark AND has_point_prevalence_average_value : 8.5 AND has_point_prevalence_range : 1-9 / 100 000 Ireland AND has_annual_incidence_average_value : 0.4 AND has_annual_incidence_range : 1-9 / 1 000 000 United States AND has_point_prevalence_average_value : 7.8 AND has_point_prevalence_range : 1-9 / 100 000 Malta AND has_annual_incidence_average_value : 0.31 AND has_annual_incidence_range : 1-9 / 1 000 000 United Kingdom AND has_point_prevalence_average_value : 8.6 AND has_point_prevalence_range : 1-9 / 100 000 Spain AND has_point_prevalence_average_value : 3.6 AND has_point_prevalence_range : 1-9 / 100 000 Ireland AND has_point_prevalence_average_value : 6.3 AND has_point_prevalence_range : 1-9 / 100 000 Belgium AND has_annual_incidence_average_value : 0.19 AND has_annual_incidence_range : 1-9 / 1 000 000 Sweden AND has_annual_incidence_average_value : 0.35 AND has_annual_incidence_range : 1-9 / 1 000 000 United States AND has_annual_incidence_average_value : 1.1 AND has_annual_incidence_range : 1-9 / 100 000 Korea, Republic of AND has_annual_incidence_average_value : 0.39 AND has_annual_incidence_range : 1-9 / 1 000 000 Iceland AND has_point_prevalence_average_value : 13.4 AND has_point_prevalence_range : 1-5 / 10 000 Worldwide AND has_point_prevalence_range : 1-9 / 100 000 Iceland AND has_annual_incidence_average_value : 0.77 AND has_annual_incidence_range : 1-9 / 1 000 000 Italy AND has_point_prevalence_average_value : 9.7 AND has_point_prevalence_range : 1-9 / 100 000
|
|
| treeView | ||
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping